SNDL Inc. is a pharmaceutical company focused on the production, distribution, and sale of cannabis derivative products. The company maintains a global customer base, providing its specialized product line to markets around the world.

The company is listed on the Canadian National Stock Exchange and conducts its financial operations in Canadian Dollars (CAD). As of the current reporting period, SNDL Inc. holds a market capitalization of 345,490,000 CAD.

Financial metrics indicate a price-to-earnings (P/E) ratio of -22.31.